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Purpose: Herding is a phenomenon by which individuals follow the behavior of others rather 
than deciding independently on the basis of their own private information. A herding-like 
phenomenon can occur in multiple sclerosis (MS) when a neurologist follows a therapeutic 
recommendation by a colleague even though it is not supported by best practice clinical guide-
lines. Limited information is currently available on the role of herding in medical care. The 
objective of this study was to determine the prevalence (and its associated factors) of herding 
in the management of MS.
Methods: We conducted a study among neurologists with expertise in MS care throughout 
Spain. Participants answered questions regarding the management of 20 case scenarios commonly 
encountered in clinical practice and completed 3 surveys and 4 experimental paradigms based 
on behavioral economics. The herding experiment consisted of a case scenario of a 40-year-old 
woman who has been stable for 3 years on subcutaneous interferon and developed a self-limited 
neurological event. There were no new magnetic resonance imaging (MRI) lesions. Her neuro-
logical examination and disability scores were unchanged. She was advised by an MS neurologist 
to switch from interferon to fingolimod against best practice guidelines. Multivariable logistic 
regression analysis was conducted to evaluate factors associated with herding.
Results: Out of 161 neurologists who were invited to participate, 96 completed the study 
(response rate: 60%). Herding was present in 75 (78.1%), having a similar prevalence in MS 
experts and general neurologists (68.8% vs 82.8%; P=0.12). In multivariate analyses, the number 
of MS patients seen per week was positively associated with herding (odds ratio [OR] 1.08, 
95% CI 1.01–1.14). Conversely, physician’s age, gender, years of practice, setting of practice, 
or risk preferences were not associated with herding.
Conclusion: Herding was a common phenomenon affecting nearly 8 out of 10 neurologists 
caring for MS patients. Herding may affect medical decisions and lead to poorer outcomes in 
the management of MS.
Keywords: multiple sclerosis, herding, disease-modifying therapy, neuroeconomics, decision-
making, risk aversion
Introduction
Medical decisions are difficult, especially when considering that they affect others: our 
patients and those who are close to them.1 The social aspects of medical decisions can 
extend beyond patients and include also colleagues, potentially with different expertise. 
For example, physicians may follow diagnostic and therapeutic recommendations 
given by other colleagues even if that decision is wrong or not supported by best 
practice guidelines in the field. Despite many years of medical training, physicians 
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have limited education in decision-making and the social 
factors that influence it.2 However, it is unclear to what degree 
physicians succumb to social influence and make erroneous 
decisions as a consequence.
In behavioral economics, herding is a phenomenon by 
which individuals follow others or imitate group behaviors 
rather than deciding independently on the basis of their own 
private information. The concept of herding has its roots in the 
work initiated by Keynes,3 who focused on the motivations to 
imitate and follow the crowd under uncertainty. Keynes3 con-
ceived herding as a response to uncertainty when individuals 
perceive their own ignorance on a specific topic.3 As a result, 
individuals may follow others’ recommendations because they 
believe that the rest of the crowd (or someone admired or well 
respected) is better informed. The propagation of information 
from a mate or the crowd rather than relying on one’s own pri-
vate signal can lead to a “cascade” of erroneous information. 
This phenomenon is one of the explanations brought forward 
for irrational financial speculation (eg, financial “bubbles”), 
which repeatedly affects economies.4
Multiple sclerosis (MS) is a chronic inflammatory demy-
elinating condition that affects the central nervous system. 
Due to its progressive nature leading to neurological dis-
ability, MS has a strong physical and emotional impact on 
patients and those who are close to them. The earlier use of 
high-efficacy disease-modifying therapies (DMTs) is recom-
mended to slow the course of MS when there is evidence of 
clinical and radiological progression.5–7 Failure to adhere 
to this recommendation may result in incorrect patient and 
family expectations and potentially suboptimal advice, treat-
ment, and outcomes.
Herding-like behavior when following erroneous deci-
sions may facilitate failure to implement best clinical practice 
(also called “negative herding”). For example, residents 
routinely follow staff recommendations, general practitio-
ners follow specialist’s advice, and specialists commonly 
follow experts in the field – also called “opinion leaders” 
even though they may provide erroneous recommenda-
tions. Although the available information from guidelines is 
public, medical decisions are based on private information. 
Each physician performs an individual assessment weighing 
patients’ factors differently (not shared with others) before 
making a decision. As a result of this herding-like behavior, 
a sequence of suboptimal or erroneous decisions may arise, 
which could lead to medical errors as observed in clinical 
practice and legal medicine.8
We tested the hypothesis that neurologists caring for MS 
patients are prone to herding-like behavior when following 
erroneous recommendations provided by colleagues. In this 
study, we assessed the prevalence of herding-like behavior 
(and associated contributing factors) in typical clinical 
decisions among physicians caring for MS patients. We spe-
cifically selected this medical condition given that MS care 
involves complex medical decisions and requires consider-
ation of multiple short- and long-term factors (eg, neuroimag-
ing results, disease progression, patient’s characteristics, and 
their preferences) and disease-modifying agents.
Methods
We conducted a web-based study (DIScUTIR MS) using 
the Qualtrics platform. It comprised 20 MS case vignettes 
regarding therapeutic recommendations among practicing 
neurologists from Spain from November 3, 2015 to March 31, 
2016. The study was approved by the Research Ethics Board 
of St Michael’s Hospital, University of Toronto, Canada. 
Written informed consent was obtained from all participants. 
We also evaluated neurologists’ ambiguity aversion, risk 
aversion, and tolerance to uncertainty. Further details of the 
protocol were published elsewhere.9
Recent meta-analysis confirmed that fingolimod, natali-
zumab, and alemtuzumab are the best available choices 
for preventing clinical relapses in patients with relapsing-
remitting multiple sclerosis (RRMS).10 The current landscape 
of DMTs for the treatment of RRMS includes first-line 
therapies (beta interferons, glatiramer acetate, terifluno-
mide, and dimethyl fumarate) and second-line therapies 
(fingolimod, natalizumab, and alemtuzumab). National and 
regional recommendations include escalating therapy from 
a first-line agent to a second-line agent when there is evi-
dence of clinical and radiological disease progression.6,11–15 
However, switching to a second-line agent is not supported 
by best practice recommendations if an MS patient has been 
clinically stable, with no new lesions on a follow-up magnetic 
resonance imaging (MRI) or no progression on the disability 
scale.6,11–15 For the current analysis, we used the aforemen-
tioned scheme according to the current clinical practice. MS 
case scenarios followed best practice guidelines supervised 
by experts in the field.
Participants
Practicing neurologists actively involved in the care of MS 
patients from across Spain were invited to participate in 
our study by the Spanish Society of Neurology (Sociedad 
Española de Neurologia-SEN). Physicians who primarily 
cared for MS patients were classified as “MS specialists”. 
All the remaining physicians were classified as “general 
neurologists”. All participants received compensation for 
completing the survey.
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herding experiment
Participants were exposed to a case scenario (illustrated 
in the following sections) describing a woman who has 
been stable on beta-interferon for 3 years with no evidence 
of radiological or disease progression (stable Expanded 
Disability Status Scale [EDSS] score of 1.5) and was assessed 
by an MS neurologist who recommended escalating therapy 
to fingolimod when not supported by the currently available 
recommendations.11,12,16 Herding-like behavior arose 
when participants followed an erroneous recommendation 
(negative herding) from an MS colleague instead of making 
an individual evidence-based decision.
Participants read the following case scenario:
A 40-year-old woman was diagnosed with MS 3 years ago. 
She has been taking subcutaneous interferon beta-1a with 
no significant side effects. Three months ago, she developed 
bilateral leg weakness and urinary urgency, which resolved 
within 2–3 weeks. An MRI of the brain at that time revealed 
a total of 10 periventricular and juxtacortical T2 lesions, 
similar to her baseline MRI. There were no gadolinium-
enhanced T1 lesions. Her neurological examination, as well 
as her EDSS score of 1.5 is unchanged from last year? She 
expressed some concerns about her recent symptoms while 
being on DMTs. She was seen by an MS colleague in your 
absence who recommended switching to fingolimod. She 
came back to your office to get your opinion.
Next, participants were asked what treatment they would 
recommend, including 1) support starting her on fingolimod 
as recommended by your MS colleague or 2) continue on 
subcutaneous interferon beta-1a.
Outcome measures
The primary outcome of the study was the proportion of 
participants who exhibited herding following a colleague 
recommendation when not supported by the current avail-
able guidelines.11,12,16 Secondary outcomes included the 
association of herding with demographic information and 
physicians’ characteristics.
statistical analysis
Chi-square tests were used to compare categorical variables; 
appropriate parametric or nonparametric tests were used to 
compare mean and median differences for continuous or 
ordinal data. A multivariable logistic regression analysis 
with adjustment for age, years of experience, number of MS 
patients seen per week, coauthor of a peer-reviewed journal in 
the last 3 years, and practice setting (academic vs community 
institution) was completed to evaluate the factors associated 
with herding. A sensitivity analysis was completed by add-
ing neurologist’s risk aversion, ambiguity aversion, and low 
tolerance to uncertainty. All the tests were 2-tailed, and the 
alpha level was set to P,0.05.
Results
Overall, 161 neurologists were invited to participate in the 
study; 136 cooperated (cooperation rate 84.5%) and 96 com-
pleted the survey (response rate 60%). There was representa-
tion from all regional territories except the Canary Islands. 
Baseline characteristics of responders are summarized in 
Table 1. The mean (SD) age was 39.5 (±8.5) years; 51 (53%) 
were female. The median time for completing the study was 
39 minutes (interquartile range [IQR] 30–52 minutes). We 
found no difference in demographic characteristics between 
participants and nonparticipants.
Herding was observed in 75 (78.1%) participants, having 
a similar prevalence in MS experts and general neurologists 
(68.8% vs 82.8%; P=0.12; Figure 1A). Participants who 
exhibited herding-like behavior had larger volume of 
MS patients seen per week than the non-herding group 
(22 vs 12 patients, respectively; P=0.03). There was no dif-
ference in herding by practice setting (physicians practicing 
in nonacademic vs academic institutions: 85.2% vs 75.4%, 
P=0.30) or years of experience (P=0.58). There was also no 
Table 1 Baseline characteristics of participants
Characteristics No of participants (%)
Age (mean ± sD), in years 39.5±8.5
gender
Female 51 (53.1)
specialty
Ms specialist  
(primarily sees Ms patients)
64 (66.7)
general neurologist who cares  
for Ms patients
32 (33.3)
Practice setting
Academic 48 (50.0)
community 26 (27.1)
Both (academic and community) 21 (21.9)
Other 1 (1.0)
% time in clinical practice
.75% 70 (72.9)
Years in practice, mean (±sD) 14.1±10
Ms patients seen per week, mean (±sD) 20±15
Attended latest ecTriMs conference 56 (58)
Author of a peer-reviewed publication 
in the last 3 years
79 (82.3)
Personality characteristics
risk aversion 19 (20.0)
Ambiguity aversion 22 (22.9)
low tolerance to uncertainty 41 (42.7)
Abbreviations: ecTriMs, european committee for Treatment and research of 
Multiple sclerosis; Ms, multiple sclerosis.
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difference in time taken for completing the herding experi-
ment between groups (herding =95 vs 102 seconds for those 
who did not herd; P=0.76) or in the prevalence of herding 
among participants completing the study below and above the 
90th percentile (60 minutes; 82.8% vs 71.1%; P=0.18).
In multivariate analysis after adjusting for confounders, 
the number of MS patients seen per week was associated with 
herding (odds ratio [OR] 1.08, 95% CI 1.01–1.16; Table 2 and 
Figure 1B). There was no association between herding and 
demographic factors or participants’ characteristics. There 
was an adequate calibration (goodness-of-fit test 0.77) and 
discrimination (area under the curve 0.808) of the model. The 
results remained consistent after adjusting for neurologists’ 
personality traits (risk aversion, aversion to ambiguity, and 
low tolerance to uncertainty) and time taken for completing 
the experiment (data not shown).
Discussion
MS patients and their treating physicians are routinely con-
fronted with uncertainties concerning diagnosis, prognosis, 
disease course, and DMTs.17 In this study, we evaluated 
whether neurologists and MS experts follow the erroneous 
advice provided by another colleague – a herding-like behav-
ior. We found that nearly 8 out of 10 participants followed 
the recommendation of an MS colleague when not supported 
by local and international best practice guidelines.11,12,16 
In the multivariable analysis, a higher volume of MS 
patients (identified by the estimated number of MS patients 
seen per week) were associated with herding-like behavior. 
Traditional demographic factors, medical experience, and 
practice setting were not related to herding-like behavior. 
This phenomenon may be explained by mental fatigue caused 
by high volume of consultations in medical situations with 
cognitively demanding decisions.18,19 For example, a study of 
585 malpractice errors found that the main contributing fac-
tor was “role overload” in more than one-third of cases.20
Another potential explanation is derived from Keynes’ 
quotation: “Worldly wisdom teaches that it is better for 
reputation to fail conventionally than to succeed unconven-
tionally”. As such, participants may have chosen switching 
therapy with the intention of being conventional (as 
recommended by an MS colleague).
Herding-like behavior is a novel concept in the medical 
field. To the best of our knowledge, there were no studies 
evaluating herding-like behavior in MS or other medical con-
ditions. The underlying concept of why people may mistak-
enly follow others’ decisions was introduced by Keynes.3 He 
believed that people purchase different objects (from a tulip 
bulb to a car or a house) at a seemingly exorbitant price not 
because they independently believe that the object is worth 
the cost, but because they believe that other people think that 
it is. In other words, some individuals believe that others 
(either peers or experts) may have better information than 
their own.21 This particular situation may more commonly 
occur under uncertainty. In repetitive situations, followers 
are being followed by other individuals, leading to further 
dissemination of misinformation.
Table 2 Factors associated with herding-like behavior
Outcomes Adjusted model for 
herding*; OR (95% CI)
Age, in years 1.02 (0.94–1.11)
gender, male 0.58 (0.19–1.76)
Time in practice, per year 0.95 (0.88–1.02)
coauthor of a recent peer-reviewed article 0.36 (0.10–1.23)
Practice setting (academic vs community) 0.29 (0.07–1.16)
low tolerance to uncertainty 0.41 (0.13–1.26)
number of Ms patients seen per week 1.08 (1.01–1.15) 
Notes: *Model derived from logistic regression including all variables of interest 
(age, gender, number of Ms patients seen per week, practice setting, academic 
profile, and tolerance to uncertainty).
Abbreviations: Ms, multiple sclerosis; Or, odds ratio.
Figure 1 Prevalence of herding-like behavior according to specialty and volume of Ms patients.
Notes: (A) herding-like behavior in Ms specialists and general neurologists. (B) Prevalence of herding-like behavior by volume of Ms patients seen per week (in terciles).
Abbreviation: Ms, multiple sclerosis.
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Given the importance of real-world evidence providing 
information on the long-term effectiveness and safety of 
disease-modifying agents, the incorporation of herding is 
likely to affect therapeutic decisions in MS care.22
Outside of the medical field, herding-like behavior has 
been described too. In aeronautics, the disintegration of the 
Space Shuttle Columbia in 200323 and the crash of Korean 
Air flight 801 in 199724 are examples of how decision-makers 
mistakenly followed the recommendation of other team 
members contributing to these catastrophes.
The presence of herding-like behavior in the medical 
domain has practical clinical and legal implications. For 
example, worse outcomes (more clinical relapses, disease 
progression) could be expected if a second physician follows 
the mistaken advice given by an MS colleague. Similarly, 
the initial erroneous interpretation of a test result (eg, a 
computed tomography scan of the head in a young individual 
with new symptoms and a focal neurological deficit) or the 
lack of initiation of an appropriate treatment (eg, prescrip-
tion of an antibiotic for a patient presenting symptoms sug-
gestive of a meningitis) followed by the second physician 
who started the shift may lead to poor clinical outcomes. 
Some medical environments may be riskier than others. 
For example, emergency care in high-volume facilities with 
high turnover of health care personnel (eg, shorter shifts) 
under time constraints may predispose to fragmented care, 
suboptimal communication, or discussion of the clinical 
plan, which could lead to herding-like behavior. Specifically, 
newly starting physicians may not be properly informed 
about the current status of patients in the ward and have 
limited time to initiate a new medical history, physical 
examination, and reassessment of test results ordered by the 
previous colleague.25,26
Limitations
Our study has some limitations that deserve comment. First, 
the case scenario may not fully capture actual decisions 
made in clinical practice. Second, our findings should be 
viewed as exploratory given the relatively small sample 
size. Finally, our study was conducted in Spain exclusively, 
thus limiting the generalizability of our results to other 
cultural contexts.
Despite these limitations, our study constitutes the first 
step toward understanding the role of herding in medical 
decisions. Furthermore, our findings highlight the influence 
of herding on therapeutic decisions in MS patients beyond 
demographic factors, medical expertise, practice setting, and 
patients’ factors or their treatment preferences. Using a novel 
approach that combines case vignettes with the elicitation of 
herding-like behavior through experiments from behavioral 
economics, we were able to expand our current understanding 
of decision-making in MS care.
Our results may not only be relevant for MS care but 
also be seen as the initial action to increase awareness for 
transferred misinformation among physicians. Herding-like 
behavior could represent the root of medicolegal cases as it 
may trigger a “string of mistakes” or cascade of errors due to 
many constraints in medical care (eg, limited allocated time, 
high volume of consultations, fragmented care, suboptimal 
communication, or discussions between the starting and 
exiting physician working shifts).8
Conclusion
Our study shows that nearly 8 out of 10 neurologists 
may exhibit negative herding by following an erroneous 
recommendation provided by an MS colleague. High patient 
volume was the single factor associated with herding. Further 
research is needed to determine the prevalence of herding 
(and its associated factors) in other medical conditions 
that could lead to poorer patients’ outcomes and result in 
medico-legal complaints.27
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